BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2003
View Archived Issues
Antiobesity effects of IL-6 in rodents
Read More
Anti-HIV effects described for green tea component
Read More
Antiinflammatory activity of AVR-118 demonstrated in animal model and clinical trial
Read More
MMV, Immtech and U. of North Carolina to develop DB-289 for malaria
Read More
GW-873140 completes phase I testing
Read More
Development agreement for MDTS formulations of Nestorone
Read More
Protherics: six-month progress report
Read More
Factor Xa inhibitor from Lilly/Tularik collaboration enters phase II
Read More
Enrollment to begin in phase I/II trial of CB-001
Read More
Novel peptide deformylase inhibitor drug candidate enters phase I
Read More
Indena claims two series of hyperforin derivatives for depression and AD
Read More
Novel antimycobacterial agents designed at U. of Central Florida
Read More
New prodrugs of LY-293558 with AMPA- and GluR5-antagonist activity covered by Lilly patent
Read More
New NR2B NMDA antagonist and its use reported by Pfizer team
Read More
Altana describes dual NO-donating gastric antisecretory agents
Read More
Novel cysteine protease inhibitors in early development at Ono
Read More
Isatoribine biologically active in HCV patients in phase Ib trial
Read More
Cyclacel acquires rights to CYC-682
Read More
EHT-0202 enters phase I study
Read More
Risperdal approved for bipolar mania
Read More
Binodenoson enters phase III
Read More
Avastin submitted for approval in Europe for colorectal cancer
Read More
Fast track status granted for HspE7 in recurrent respiratory papillomatosis
Read More
Dual-acting estrogen sulfatase inhibitor and SERM presented in San Antonio
Read More
JNJ-6368661 characterized as potent, orally active anticoagulant and antithrombotic agent
Read More
Selective platelet TP receptor antagonist BM-613 synthesized by Belgian researchers
Read More
S-40503: a novel SARM with selective effects on bone in rat models of osteoporosis
Read More
hTERT-based vaccine approaches to breast cancer
Read More